STAAR Surgical (STAA) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

STAAR Surgical Revenue Highlights

Latest Revenue (Y)

$313.90K

Latest Revenue (Q)

$42.59M

Main Segment (Y)

Implantable Collamer Lenses

Main Geography (Y)

Other Countries

STAAR Surgical Revenue by Period

STAAR Surgical Revenue by Year

Date	Revenue	Change
2024-12-27	$313.90K	-99.90%
2023-12-29	$322.42M	13.37%
2022-12-30	$284.39M	23.40%
2021-12-31	$230.47M	41.00%
2021-01-01	$163.46M	8.84%
2020-01-03	$150.19M	21.16%
2018-12-28	$123.95M	36.80%
2017-12-29	$90.61M	9.92%
2016-12-30	$82.43M	6.88%
2016-01-01	$77.12M	2.85%
2015-01-02	$74.99M	3.84%
2014-01-03	$72.22M	13.22%
2012-12-28	$63.78M	1.62%
2011-12-30	$62.77M	14.21%
2010-12-31	$54.96M	-27.06%
2010-01-01	$75.34M	0.60%
2009-01-02	$74.89M	26.16%
2007-12-28	$59.36M	5.47%
2006-12-29	$56.28M	9.71%
2005-12-30	$51.30M	-0.74%
2004-12-31	$51.69M	2.43%
2004-01-02	$50.46M	4.58%
2003-01-03	$48.25M	-3.96%
2001-12-28	$50.24M	-6.94%
2000-12-29	$53.99M	-8.50%
1999-12-31	$59.00M	8.86%
1999-01-01	$54.20M	27.53%
1998-01-02	$42.50M	0.71%
1997-01-03	$42.20M	21.61%
1995-12-29	$34.70M	26.64%
1994-12-31	$27.40M	36.32%
1993-12-31	$20.10M	-

STAAR Surgical generated $313.90K in revenue during NA 2024, up -99.90% compared to the previous quarter, and up 0.21% compared to the same period a year ago.

STAAR Surgical Revenue by Quarter

Date	Revenue	Change
2025-03-28	$42.59M	-12.99%
2024-12-27	$48.95M	-44.75%
2024-09-27	$88.59M	-10.52%
2024-06-28	$99.00M	27.99%
2024-03-29	$77.36M	1.42%
2023-12-29	$76.27M	-5.02%
2023-09-29	$80.31M	-13.00%
2023-06-30	$92.31M	25.54%
2023-03-31	$73.53M	14.81%
2022-12-30	$64.04M	-15.78%
2022-09-30	$76.05M	-6.23%
2022-07-01	$81.10M	28.32%
2022-04-01	$63.20M	7.12%
2021-12-31	$59.00M	1.11%
2021-10-01	$58.35M	-6.44%
2021-07-02	$62.37M	22.89%
2021-04-02	$50.75M	10.34%
2021-01-01	$46.00M	-2.30%
2020-10-02	$47.08M	33.78%
2020-07-03	$35.19M	0.02%
2020-04-03	$35.19M	-9.51%
2020-01-03	$38.88M	-0.44%
2019-09-27	$39.05M	-1.54%
2019-06-28	$39.66M	21.73%
2019-03-29	$32.58M	4.48%
2018-12-28	$31.19M	-1.84%
2018-09-28	$31.77M	-6.30%
2018-06-29	$33.91M	25.14%
2018-03-30	$27.09M	9.02%
2017-12-29	$24.85M	5.87%
2017-09-29	$23.47M	7.01%
2017-06-30	$21.94M	7.79%
2017-03-31	$20.35M	-8.07%
2016-12-30	$22.14M	10.40%
2016-09-30	$20.05M	-4.40%
2016-07-01	$20.97M	8.85%
2016-04-01	$19.27M	2.77%
2015-10-02	$18.75M	0.50%
2015-07-03	$18.66M	-1.07%
2015-04-03	$18.86M	13.79%
2015-01-02	$16.57M	-8.88%
2014-10-03	$18.19M	-9.28%
2014-07-04	$20.05M	-0.64%
2014-04-04	$20.18M	6.51%
2014-01-03	$18.94M	10.74%
2013-09-27	$17.11M	-5.82%
2013-06-28	$18.16M	0.91%
2013-03-29	$18.00M	9.32%
2012-12-28	$16.47M	3.79%
2012-09-28	$15.87M	-0.48%
2012-06-29	$15.94M	2.79%
2012-03-30	$15.51M	-5.32%
2011-12-30	$16.38M	7.30%
2011-09-30	$15.27M	-6.17%
2011-07-01	$16.27M	9.56%
2011-04-01	$14.85M	3.20%
2010-12-31	$14.39M	9.41%
2010-10-01	$13.15M	-3.57%
2010-07-02	$13.64M	-1.01%
2010-04-02	$13.78M	-30.52%
2010-01-01	$19.83M	9.48%
2009-10-02	$18.11M	-5.25%
2009-07-03	$19.12M	4.56%
2009-04-03	$18.28M	0.69%
2009-01-02	$18.16M	0.25%
2008-09-26	$18.11M	-12.35%
2008-06-27	$20.66M	15.06%
2008-03-28	$17.96M	13.06%
2007-12-28	$15.88M	-

STAAR Surgical generated $42.59M in revenue during Q1 2025, up -12.99% compared to the previous quarter, and up 55.84% compared to the same period a year ago.

STAAR Surgical Revenue Breakdown

STAAR Surgical Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 22	Dec 21	Jan 21	Jan 20
Implantable Collamer Lenses	$312.54M	$269.71M	$212.91M	$141.41M	$129.32M
Other Surgical Products	$1.36M	$5.04M	$5.05M	$8.48M	$5.17M
Cataract Intraocular Lenses	-	$9.64M	$12.52M	-	-
Intraocular Lenses	-	-	-	$13.57M	$15.69M

STAAR Surgical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Implantable Collamer Lenses (99.57%), and Other Surgical Products (0.43%).

Quarterly Revenue by Product

Product/Service	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jul 22	Apr 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20
Implantable Collamer Lenses	$41.50M	$146.29M	$89.10M	$77.15M	$319.43M	$81.07M	$93.11M	$70.63M	$61.16M	$71.95M	$77.92M	$58.67M	$54.15M	$59.23M	$46.50M	$39.85M	$41.49M	$30.73M	$29.34M	$33.29M
Other Surgical Products	$1.09M	$1.15M	$205.00K	$1.85M	$-540.00K	$-846.00K	$1.43M	$884.00K	$1.90M	$632.00K	$1.62M	$1.67M	$58.00K	$526.00K	$2.46M	$2.26M	$1.91M	$1.85M	$1.89M	-
Cataract Intraocular Lenses	-	-	-	-	$1.14M	$221.00K	$40.00K	$1.48M	$2.00M	$2.19M	$2.55M	$2.90M	$2.52M	-	-	-	-	-	-	-
Intraocular Lenses	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.07M	$3.73M	$3.69M	$3.33M	$2.56M	$3.99M	$3.71M

STAAR Surgical's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Implantable Collamer Lenses (97.44%), and Other Surgical Products (2.56%).

STAAR Surgical Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 18
UNITED STATES	$7.32M
Other Countries	$47.42M
JAPAN	$23.15M
CHINA	$46.07M

STAAR Surgical's latest annual revenue breakdown by geography, as of Dec 18: Other Countries (38.25%), CHINA (37.17%), JAPAN (18.68%), and UNITED STATES (5.90%).

Quarterly Revenue by Country

Country	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
CHINA	$18.36M	$19.39M	$11.77M	$10.85M	$13.35M	$13.96M	$7.91M
Other Countries	$13.35M	$13.99M	$12.00M	$7.65M	$12.41M	$13.25M	$10.15M
JAPAN	$7.34M	$6.28M	$5.52M	$5.37M	$6.01M	$6.69M	$5.08M
KOREA, REPUBLIC OF	-	-	$3.29M	$2.19M	-	-	-
UNITED STATES	-	-	-	-	-	-	$1.76M

STAAR Surgical's latest quarterly revenue breakdown by geography, as of Sep 19: CHINA (47.01%), Other Countries (34.18%), and JAPAN (18.81%).

STAAR Surgical Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
NEOG	Neogen	$894.66M	$209.19M
OPK	OPKO Health	$713.14M	$156.81M
AZTA	Azenta	$656.32M	$143.94M
ESTA	Establishment Labs	$166.03M	$51.30M
BLFS	BioLife Solutions	$82.25M	$23.94M
KMTS	Kestra Medical	$27.81M	$17.23M
TSHA	Taysha Gene Therapies	$8.33M	$1.99M
NNNN	Anbio Biotechnology Class A Ordinary Shares	$8.19M	$2.53M
STAA	STAAR Surgical	$313.90K	$42.59M
PLSE	Pulse Biosciences	-	-
TRML	Tourmaline Bio	-	-

STAA Revenue FAQ

What is STAAR Surgical’s yearly revenue?

STAAR Surgical's yearly revenue for 2024 was $313.9K, representing a decrease of -99.90% compared to 2023. The company's yearly revenue for 2023 was $322.42M, representing an increase of 13.37% compared to 2022. STAA's yearly revenue for 2022 was $284.39M, representing an increase of 23.40% compared to 2021.

What is STAAR Surgical’s quarterly revenue?

STAAR Surgical's quarterly revenue for Q1 2025 was $42.59M, a -12.99% decrease from the previous quarter (Q4 2024), and a -44.94% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $48.95M, a -44.75% decrease from the previous quarter (Q3 2024), and a -35.82% decrease year-over-year (Q4 2023). STAA's quarterly revenue for Q3 2024 was $88.59M, a -10.52% decrease from the previous quarter (Q2 2024), and a 10.31% increase year-over-year (Q3 2023).

What is STAAR Surgical’s revenue growth rate?

STAAR Surgical's revenue growth rate for the last 3 years (2022-2024) was -99.89%, and for the last 5 years (2020-2024) was -99.81%.

What are STAAR Surgical’s revenue streams?

STAAR Surgical's revenue streams in c 24 are Implantable Collamer Lenses, and Other Surgical Products. Implantable Collamer Lenses generated $312.54M in revenue, accounting 99.57% of the company's total revenue, up 15.88% year-over-year. Other Surgical Products generated $1.36M in revenue, accounting 0.43% of the company's total revenue, down -73.06% year-over-year.

What is STAAR Surgical’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of STAAR Surgical was Implantable Collamer Lenses. This segment made a revenue of $312.54M, representing 99.57% of the company's total revenue.